• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY INTERNATIONAL LTD - 8010379 PFC SIG RPF INS SZ 3 10MM; PFC SIGMA RP-F : KNEE TIBIAL INSERT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY INTERNATIONAL LTD - 8010379 PFC SIG RPF INS SZ 3 10MM; PFC SIGMA RP-F : KNEE TIBIAL INSERT Back to Search Results
Catalog Number 951030
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); No Code Available (3191)
Date of Event 09/27/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
The customer reports that a total knee prosthesis was implanted on (b)(6) 2017: a cement palacos r40 + gentamicine code product 66017750 and lot number 85654581 revision on (b)(6) 2019 to remove and to change the prosthesis.During the revision, we noticed an abnormal mobility of the tibial implant which was removed without problem.A prosthesis with a hinge was implanted.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Revision was done for chronic pain.
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: product complaint (b)(4).Investigation summary: no device was received.Root cause undetermined.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PFC SIG RPF INS SZ 3 10MM
Common Device Name
PFC SIGMA RP-F : KNEE TIBIAL INSERT
Manufacturer (Section D)
DEPUY INTERNATIONAL LTD - 8010379
st. anthony's road
leeds LS11 8DT
UK  LS11 8DT
MDR Report Key9278464
Report Number1818910-2019-114045
Device Sequence Number19536061
Product Code NJL
UDI-Device Identifier10603295230373
UDI-Public10603295230373
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
P830055
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 10/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number951030
Device Lot Number438943
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/08/2019
Supplement Date Received by Manufacturer10/08/2019
11/28/2019
01/06/2020
Initial Report FDA Received Date11/05/2019
Supplement Report FDA Received Date11/05/2019
12/26/2019
01/06/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CIMENT PALACOS R40 + GENTAMICINE
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
Patient Weight65
-
-